APA (7th ed.) Citation

AAM, A. E., MJ, A., M, K., I, D., F, A., JA, M., . . . NK, T. (2026). Beyond the JAK2 mutation: The inflammasome, clonal stability, and the thrombotic niche in myeloproliferative neoplasms. Clinical and experimental medicine, 26(1), . https://doi.org/10.1007/s10238-026-02247-8

Chicago Style (17th ed.) Citation

AAM, Abdelgawwad El-Sehrawy, Al-Khreisat MJ, Kibriyeva M, Dilbar I, Axmedova F, Mohammed JA, Mishra S, and Tailor NK. "Beyond the JAK2 Mutation: The Inflammasome, Clonal Stability, and the Thrombotic Niche in Myeloproliferative Neoplasms." Clinical and Experimental Medicine 26, no. 1 (2026). https://doi.org/10.1007/s10238-026-02247-8.

MLA (9th ed.) Citation

AAM, Abdelgawwad El-Sehrawy, et al. "Beyond the JAK2 Mutation: The Inflammasome, Clonal Stability, and the Thrombotic Niche in Myeloproliferative Neoplasms." Clinical and Experimental Medicine, vol. 26, no. 1, 2026, https://doi.org/10.1007/s10238-026-02247-8.